🚀 Clinakos Inc. is proud to be recognized as a key player in shaping the future of AI-driven oncology alongside market leaders including Nvidia, ConcertAI, Oracle, PathAI, CureMatrix, @Tempus, GE Healthcare, Siemens Healthineers, Medrtonic, Roche, Insilico Medicone, and others. 

According to the latest AI in Oncology Market report from MarketsandMarkets, the global market is set to grow from US $2.45 billion in 2024 to US $11.52 billion by 2030, achieving an impressive 29.4% CAGR.

This rapid growth is fueled by AI breakthroughs in:

🔹Early cancer detection

🔹Precision oncology & personalized care

🔹Clinical decision support

🔹AI-enabled drug discovery

At Clinakos, our mission is clear: to harness the power of real-world data, advanced analytics, and AI technology to empower healthcare providers, researchers, and life sciences organizations with actionable insights that improve patient outcomes.

💡Being listed alongside global technology and healthcare leaders is both an honor and a testament to our team’s relentless commitment to innovation in cancer care.

Curious to learn more? Read the full report here